Lipitor Lawsuits Consolidated in South Carolina Federal Court for...
Court Documents Indicate 68 Lipitor Diabetes Claims Are Now Pending in New Multidistrict Litigation, Additional Lipitor Lawsuits Expected to Be Transferred to South Carolina(PRWeb March 11, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11655530.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 11, 2014 Category: Pharmaceuticals Source Type: news

Over 64 000 Bottles of Ranbaxy's Generic Lipitor RecalledOver 64 000 Bottles of Ranbaxy's Generic Lipitor Recalled
The second recall of generic atorvastatin by the Indian drug maker comes after a pharmacist found a 10-mg-dose bottle to contain a 20-mg pill. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2014 Category: Cardiology Tags: Cardiology News Alert Source Type: news

More India-made generic Lipitor recalled
Recall is latest in series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the U.S., its biggest market. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 10, 2014 Category: Consumer Health News Source Type: news

Generic Lipitor Recalled Again (FREE)
By the Editors Ranbaxy has recalled over 60,000 bottles of generic atorvastatin after … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 10, 2014 Category: Primary Care Source Type: news

Ranbaxy recalls some batches of generic Lipitor in latest quality blow
MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Ranbaxy Laboratories recalls over 64,000 bottles of generic Lipitor in US
Ranbaxy has recalled more than 64,000 bottles of generic Lipitor in the US due to reports of a dose mix-up, US regulators said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2014 Category: Pharmaceuticals Source Type: news

Ranbaxy recalls over 64,000 bottles of generic Lipitor in U.S
(Reuters) - Indian drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Ranbaxy Recalls Generic Lipitor in U.S.
Ranbaxy Laboratories, the India-based generic-drug maker beset by manufacturing-quality problems, has issued another recall of generic versions of the cholesterol drug Lipitor in the U.S. because of a potential dose mix-up. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Lipitor Without a Rx? Pfizer Pushes Ahead With OTC PlansLipitor Without a Rx? Pfizer Pushes Ahead With OTC Plans
Pfizer has launched a 1200-patient study to investigate whether patients could successfully take OTC Lipitor. Patients would make treatment decisions once they obtained their own blood tests. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news

Who Stands To Gain With FDA Approval Of OTC Lipitor?
However, insurance companies will also be big winners, as medical insurance doesn’t cover OTC medications. Insurers will no longer need to pay for 10mg Lipitor prescriptions and, eventually, 10 mg generic atorvastatin prescriptions as well. Furthermore, in all likelihood, insurers will lobby hard to convert as many statin users as possible to OTC Lipitor. In doing so, they will perhaps shift as much as $1 billion of costs that they now have onto consumers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 4, 2014 Category: Pharmaceuticals Authors: John LaMattina Source Type: news

Pfizer Starts Testing For Over-The-Counter Lipitor
Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in the Wall Street Journal that the company has started a clinical study to support the application for low-dose atorvastatin (10 mg). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 3, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Pfizer Moves to Prop Up Lipitor
Pfizer hopes to overcome skepticism that consumers can appropriately take an over-the-counter version of cholesterol pill Lipitor without doctor guidance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 3, 2014 Category: Pharmaceuticals Tags: FREE Source Type: news

Pfizer Faces Regulatory Action From Australian Government
Drug industry giant Pfizer is now facing regulatory action from the Australian government. The government’s competition regulator, the Australian Competition and Consumer Commission (ACCC) has said that Pfizer has illegally marketed the cholesterol drug Lipitor to Australian pharmacies, in direct violation of antitrust law. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - February 21, 2014 Category: Pharmaceuticals Source Type: news

Lipitor MDL News: Zoll, Kranz & Borgess Notes The Lipitor MDL Is...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor.(PRWeb February 20, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11601175.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 20, 2014 Category: Pharmaceuticals Source Type: news